Sector: Health Care | Focus: Life Sciences Tools & Services
HQ: Waltham, Massachusetts
Financial Risks
The company faces potential costs from environmental remediation, pending litigation (product liability, intellectual property, employment, and commercial), and uncertain outcomes of these matters. Unrecognized tax benefits could reduce the effective tax rate. Fluctuations in foreign currency exchange rates and general economic conditions pose risks to international operations and customer spending. The company's reliance on customer capital spending and government funding also presents a risk.
Financial Upside
The company's acquisitions, including Olink Holding AB, The Binding Site Group, and CorEvitas, LLC, aim to enhance capabilities and expand market share. Strong commercial execution, productivity improvements, and strategic investments in areas like sales reach and research & development are expected to drive growth. The company's access to capital markets and free cash flow generation support future acquisitions, share buybacks, and dividends.
